Saturday, October 26, 2019

FW: (LML) MALTALEP trial - discussion

 

Leprosy Mailing List October 26,  2019

Ref.:    (LML) MALTALEP trial - discussion

From:  Marcos Virmond, Bauru, Brazil


 

Dear Pieter

 

Among the many interesting points raised by Lockwood et al. in their recent message (LML, 25-10-2019), let me stress one above all: "The reinvigoration of contact examination has been a positive outcome of chemoprophylaxis strategies and....".

 

Congratulations to Prof. Lockwood for bringing this important point back to the present discussions. Indeed, this aspect has been frequently overlooked. I stressed this positive aspect of chemoprophylaxis in an early LPEP meeting many years ago in Surabaya, Indonesia, and I am very happy that, finally, this relevant "side effect" of chemoprophylaxis is back to the discussions. Obviously, one cannot implement chemoprophylaxis for this sole reason. However, one should consider this point while discussing any chemoprophylaxis strategy.

 

Marcos Virmond

ILSL-Bauru


LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

 

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web, visit https://groups.google.com/d/msgid/leprosymailinglist/a91018c4-7171-4b3e-bb7e-9809af95bb12%40googlegroups.com.

No comments: